Subsequently, the solution was subjected to dialysis using a dialysis bag with a molecular weight cutoff of 800014,000 Da
Some patients may find that staying on a maintenance dose or reducing to a lower dose remains the better choice
13 The benefits derived from preserving muscle mass during GLP-1 therapy are not merely about counteracting a potential negative aspect of weight loss
However, these numbers came at 30 weeks
This was a specific and unexpected side effect, reported by a large percentage of patients, and, again, less likely to be a placebo effect
Tirzepatide, on the other hand, is a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist